CIBC Asset Management
VYGR icon

CIBC Asset Management’s Voyager Therapeutics VYGR Stock Holding History

CIBC Asset Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.8K Hold
11,335
– – ﹤0.01% 1352
2025
Q4 		$44.5K Buy
+11,335
New +$50.1K ﹤0.01% 1351

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIBC Asset Management's VYGR Position: Q1 2026 in Review

CIBC Asset Management held its Voyager Therapeutics (VYGR) position steady in Q1 2026 at 11,335 shares worth $43.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1352.

CIBC Asset Management first reported a position in VYGR in Q4 2025 and has held it in 2 quarters since. The position peaked at $44.5K in Q4 2025. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • CIBC Asset Management held 11,335 shares of Voyager Therapeutics worth $43.8K as of Q1 2026.
  • CIBC Asset Management left its Voyager Therapeutics share count unchanged in Q1 2026.
  • Voyager Therapeutics made up ﹤0.01% of CIBC Asset Management's portfolio in Q1 2026, its #1352 holding.
  • CIBC Asset Management first reported a position in Voyager Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • CIBC Asset Management's Voyager Therapeutics position peaked at $44.5K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.